Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Injectable bulking agents for treating faecal incontinence.

C J Vaizey1, M A Kamm

  • 1Department of Physiology, St Mark's Hospital at Northwick Park, Watford Road, Harrow HA1 3UJ, UK. carolynne.vaizey@nwlh.nhs.uk <carolynne.vaizey@nwlh.nhs.uk>

The British Journal of Surgery
|April 27, 2005
PubMed
Summary

Injectable bulking agents are increasingly used for fecal incontinence despite limited evidence. A wide product selection and undefined injection methods hinder robust clinical trials for this treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sexual Function After Obstetric Anal Sphincter Injuries (OASIs): A Systematic Review and Meta-Analysis.

International urogynecology journal·2026
Same author

Care pathways and anorectal evaluation for obstetric anal sphincter injury-related incontinence: A UK survey of obstetricians.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2025
Same author

Laparoscopic modified mesh rectopexy: medium-term results of a novel approach for external rectal prolapse.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2023
Same author

Are rectal prolapse repairs too diverse and complex for simple database analysis?

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2023
Same author

Effect of food additives on key bacterial taxa and the mucosa-associated microbiota in Crohn's disease. The ENIGMA study.

Gut microbes·2023
Same author

Letter: tofacitinib in biologic-experienced ulcerative colitis-a single-centre real-world experience in Australia.

Alimentary pharmacology & therapeutics·2021

Area of Science:

  • Gastroenterology
  • Urology
  • Plastic Surgery

Background:

  • Injectable bulking agents for fecal incontinence are primarily supported by limited pilot studies.
  • Despite sparse data, their clinical application is rapidly expanding.
  • Bulking agents have a longer history in treating urinary incontinence.

Purpose of the Study:

  • To review available injectable bulking agents for fecal incontinence.
  • To summarize delivery methods based on existing literature and related surgical fields.

Main Methods:

  • Literature review of pilot studies on fecal incontinence bulking agents.
  • Inclusion of articles on agent use in urology, plastic surgery, and laryngology.
  • Consideration of relevant animal studies.

Related Experiment Videos

Main Results:

  • A variety of bulking agent products are now available for fecal incontinence.
  • Experience from related surgical fields informs current practices.
  • Animal studies provide supplementary data.

Conclusions:

  • The use of bulking agents for fecal incontinence remains limited compared to urinary incontinence.
  • The proliferation of products and absence of standardized injection protocols present challenges.
  • Developing well-designed, prospective randomized trials for fecal incontinence treatment is hampered by current limitations.